Department of Hematology Researcher Highlights Recent Research in Myeloma (Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes)

Related content

• Research output

• Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes

  Research output: Contribution to journal › Article › peer-review